Cleared Traditional

K143079 - Endovascular Stent Planning Software

K143079 is an FDA 510(k) clearance for Endovascular Stent Planning Software, manufactured by Vital Images, Inc.. The device is a Class 2 Radiology device with product code LLZ cleared through the Traditional 510(k) pathway after a 38-day FDA review.

K143079 · Vital Images, Inc. · Radiology device
Download Printable Device Report (PDF)
Optimized for regulatory review, auditing and printing
Dec 2014
Decision
38d
Days
Class 2
Risk

K143079 is an FDA 510(k) clearance for the Endovascular Stent Planning Software. Classified as System, Image Processing, Radiological within the LLZ classification (a category encompassing advanced image processing and PACS-adjacent software), Class II - Special Controls.

Submitted by Vital Images, Inc. (Minnetonka, US). The FDA issued a Cleared decision on December 4, 2014 after a review of 38 days - a notably fast clearance cycle.

This device falls under the Radiology FDA review panel, regulated under 21 CFR 892.2050 - the FDA radiology and imaging software oversight framework. The Traditional 510(k) pathway establishes clearance through substantial equivalence to a legally marketed predicate device, without requiring clinical trial data.

Device pattern: Incremental AI imaging tool. Moderate equivalence dependency. Overall, this clearance reflects a predicate-aligned approval typical of modern AI radiology extensions - not a novel clinical breakthrough, but a validated iteration within an established regulatory category.

View all Vital Images, Inc. devices

FDA 510(k) Submission Details - K143079

510(k) Number K143079 FDA.gov
FDA Decision Cleared Substantially Equivalent - Traditional 510(k) (SESE)
Date Received October 27, 2014
Decision Date December 04, 2014
Days to Decision 38 days
Submission Type Traditional
Review Panel Radiology (RA)
Summary Summary PDF
Third-party Review No - reviewed directly by FDA
Combination Product No
PCCP Authorized No
Regulatory Context
Review time vs. panel average
69d faster than avg
Panel avg: 107d · This submission: 38d
Pathway characteristics
Predicate-based equivalence. No clinical trials required.

LLZ Device Classification - Class 2, Special Controls

Product Code LLZ System, Image Processing, Radiological
Device Class Class 2 - Special Controls
CFR Regulation 21 CFR 892.2050
What this classification means

Class II devices require demonstration of substantial equivalence to a legally marketed predicate device. This pathway does not require clinical trials - it relies on engineering equivalence and performance data. Most Radiology devices follow this clearance model.

Regulatory Peers - LLZ System, Image Processing, Radiological

All 1724
Devices cleared under the same product code (LLZ) and FDA review panel - the closest regulatory comparables to K143079.
IPACS MEDICAL IMAGE MANAGEMENT SYSTEM
K140797 · Visbion Limited · Dec 2014
eSie Apps Suite
K143254 · Siemens Medical Solutions USA, Inc. · Dec 2014
ONEFIT HIP PLANNER
K142671 · Onefit Medical · Dec 2014
Synapse 3D Liver and Kidney Analysis
K142521 · Fujifilm Meidcal Systems U.S.A.,Inc. · Dec 2014
IMPLANT STUDIO
K141570 · 3Shape Medical A/S · Oct 2014
IQQA-BODYIMAGING SOFTWARE
K141745 · Edda Technology · Oct 2014